United States (US) health regulators on Friday estimated that BQ.1 and closely related BQ.1.1 accounted for 16.6% of coronavirus variants in the country, nearly doubling from last week, while Europe expects them to become the dominant variants in a...

Pharma major BioNTech plans to start construction on its first start-to-finish vaccine plant in Africa in the middle of next year, Bloomberg reports (www.bloomberg.com/news/articles/2021-10-26/biontech-to-start-building-vaccine-plant-in-africa-next-year). The German company said it is developing the plans with the governments of Rwanda and Senegal,...